- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02337075
PAthway To Health (PATH): Fostering Culturally Appropriate Physical Activities in Indigenous Communities (PATH)
PAthway To Health (PATH): Fostering Culturally Appropriate Physical Activities Using Digital Technology in Indigenous Communities
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Background: Promoting an active lifestyle is a priority identified by the communities served by KDC Health. Statistics Canada estimates obesity in one in four adults based on 2007-2009 data, with higher prevalence among Indigenous people compared to non-Aboriginal population (between 26% and 36% among adults living off-reserve and on-reserve, respectively). Furthermore, Indigenous people also report higher prevalence of obesity associated complications, including diabetes, cardiovascular disease, and arthritis. The association between physical inactivity and obesity suggests that increasing physical activity is important.
KDC Health offers a variety of free programs to community members, however, the use of these services has been low. KDC Health has previously partnered with the CIHR-funded IMPAKT project, and has expressed a strong interest in developing an intervention to improve health and wellness in the communities.
Objectives:
- To determine whether the PATH program can improve physical activity participation in the communities served by KDC Health.
- To assess the effect of this program on reducing sedentary time, and increasing the use of health promotion and wellness services offered by KDC Health
- To assess the correlation of physical activity levels and the secondary outcome measures among individuals who are living in the same household.
Methods: The investigators will conduct a community-based proof-of-concept randomized controlled trial (RCT) with 60 eligible participants. Only 1 member per household will be enrolled. If more than 1 member is interested, they will select 1 person by consensus or by a random draw.
After obtaining the baseline measures, participants will be randomly assigned to the 'Now Group' (target=30) or 'Later Group' (target=30).
The Now Group will participate in a brief education session held at the KDC Health Centre, use a wearable physical activity tracker (Fitbit Flex), and physical activity mentoring by a KDC Health Staff (the Activity Mentors). The Activity Mentors have received training for the project from the Principal Investigator. In Month 1-2, participants will meet with their Activity Mentor once every 2 weeks to review their physical activity status, activity goals, and the health programs available at the Centre. In Month 3-4, they will continue to use Fitbit Flex but will no longer have regular meetings with the Activity Mentor.
The Later Group will receive intervention two months later (i.e., Month 3-4).
The primary outcome measure will be the time spent in moderate/vigorous physical activity. In addition, time spent in sedentary behaviours will be recorded. Participants will wear a SenseWear Mini accelerometer for 7 days at baseline, 2 months, and 4 months. Secondary outcome measures include sedentary time measured with SenseWear Mini, health status that will be measured using the SF-36 (a generic measure of health-related quality of life), and body weight. Participants' use of KDC Health programs and their motivation to be physically active will also be recorded.
At the end of the program, participants will be interviewed for 30 minutes in person about their opinion on the intervention. Interviews will focus on 1) barriers/facilitators to being physically active, 2) their experience with the intervention, and 3) the nature of activities they engage in.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
British Columbia
-
Richmond, British Columbia, Canadá, V6X 2C7
- Arthritis Research Canada
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria: Participants are eligible if they:
- Are a person from KDC Health Member Nations
- Are 19 years or older
- Have no health condition that prevents them from being physically active
- Are able to participate in a 4-month project -
Exclusion Criteria: Participants are not eligible to participate if they:
- Do not meet the criteria above
- Use medication that may impair activity tolerance (e.g., beta blockers),
- Are unable to provide informed consent -
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Now Group - PATH Program
The Now Group will receive the PATH program.
They will participate in a brief education session, use a wearable physical activity tracker, and physical activity mentoring by an Activity Mentors.
In Month 1 and 2, participants will meet with their Activity Mentor once every 2 weeks to review their physical activity status, activity goals, and the health programs available at the Centre.
In Month 3 and 4, they will continue to use physical activity tracker but will no longer have regular meetings with the Activity Mentor.
|
A brief education session, use of a wearable physical activity tracker, and physical activity mentoring by an Activity Mentor every 2 weeks.
|
|
Comparador activo: Later Group
The Later Group will receive the PATH program in Month 1-2.
Intervention will be provided two months later (i.e., Month 3 and 4).
|
A brief education session, use of a wearable physical activity tracker, and physical activity mentoring by an Activity Mentor every 2 weeks.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time spent in Moderate to Vigorous Physical Activity (MVPA), measured by SenseWear Mini accelerometer
Periodo de tiempo: Change from baseline in Time spent in MVPA at 2 months and 4 months
|
Participants will wear a SenseWear Mini accelerometer for 7 days at baseline, and Months 2 and 4.
|
Change from baseline in Time spent in MVPA at 2 months and 4 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Time spent in sedentary behaviours, measured by SenseWear Mini accelerometer
Periodo de tiempo: Change from baseline in time spent in sedentary behaviours at 2 months and 4 months
|
Participants will wear a SenseWear Mini accelerometer for 7 days at baseline, and Months 2 and 4.
|
Change from baseline in time spent in sedentary behaviours at 2 months and 4 months
|
|
Change in Health Status, measured by SF-36 Questionnaire
Periodo de tiempo: Change from baseline health status at 2 months and 4 months
|
SF-36 Questionnaire
|
Change from baseline health status at 2 months and 4 months
|
|
Change in Body weight, measured by measured with a calibrated scale
Periodo de tiempo: Change from baseline body weight at 2 months and 4 months
|
Measured with a calibrated scale
|
Change from baseline body weight at 2 months and 4 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Linda Li, PT, PhD, Arthritis Research Canada
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- H12-02526
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .